Zio Patch Wear Duration
The Zio patch should be worn continuously for up to 14 days to maximize arrhythmia detection. 1
Recommended Wear Time
The Zio XT patch is designed as an external patch recorder that continuously records and stores rhythm data for 2-14 days 1. This extended monitoring window is critical because:
Most arrhythmias are detected after the first 48 hours: Among patients with detected arrhythmias, 29.9% had their first arrhythmia and 51.1% had their first symptom-triggered arrhythmia occur after the initial 48-hour period 2
Diagnostic yield increases significantly with longer wear time: The overall diagnostic yield was substantially higher when data from the entire wear duration were analyzed compared to just the first 48 hours (62.2% vs 43.9% for any arrhythmia, p<0.0001) 2
Real-world compliance supports extended wear: In a large study of 26,751 consecutive patients, the mean wear time was 7.6 ± 3.6 days with a median analyzable time of 99% of total wear time 2
Clinical Context
The extended monitoring capability of the Zio patch addresses a fundamental limitation of traditional 24-72 hour Holter monitors. For paroxysmal atrial fibrillation specifically, the interval to first detection was inversely proportional to AF burden, with increasing proportions detected after 48 hours (38% of patients with <1% AF burden had their first detection after 48 hours) 2.
In pediatric populations, the median duration of monitoring was 5 days, and 56% of findings requiring intervention or increased surveillance were first identified beyond 24 hours 3.
Practical Application
- Apply the patch and instruct patients to wear it continuously for the full 14-day period
- The device is water-resistant but should be removed before showering in some models
- Patients should activate the trigger button when experiencing symptoms
- The patch automatically detects and records arrhythmias even without patient activation 1
The 14-day continuous monitoring period is supported by ACC/AHA/HRS guidelines that classify external patch recorders as Class IIa for selected patients with syncope or suspected arrhythmias 1.